Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

Completed · Phase 2

Conditions studied: Cervical Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with cisplatin and vinorelbine in treating patients with refractory or recurrent squamous cell cervical cancer that has not responded to local therapy.

Key facts

Study ID

NCT00002813

Run by

Gynecologic Oncology Group

People needed

62

Starts

1997-08-01

Last updated by the study team

2013-05-27

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Chao Family Comprehensive Cancer Center — Orange, California, United States
• MBCCOP - Hawaii — Honolulu, Hawaii, United States
• Johns Hopkins Oncology Center — Baltimore, Maryland, United States
• CCOP - Ann Arbor Regional — Ann Arbor, Michigan, United States
• Cancer Center of Albany Medical Center — Albany, New York, United States
• Comprehensive Cancer Center of Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States
• CCOP - Upstate Carolina — Spartanburg, South Carolina, United States
• Brookview Research, Inc. — Nashville, Tennessee, United States
• University of Texas - MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.